Properties (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Psychologist
|
| gptkbp:associatedWith |
thyroid disorders
thymoma |
| gptkbp:canBe |
fatigue
difficulty speaking difficulty swallowing |
| gptkbp:canLeadTo |
respiratory failure
myasthenic crisis |
| gptkbp:causedBy |
autoimmune response
|
| gptkbp:commonName |
men over 60
women under 40 |
| gptkbp:decidedBy |
illness
stress heat |
| gptkbp:demographics |
1 in 5,000 people
|
| gptkbp:diseaseResistance |
clinical examination
electromyography |
| https://www.w3.org/2000/01/rdf-schema#label |
myasthenia gravis
|
| gptkbp:impact |
muscle strength
immunosuppressants anticholinesterase medications thymectomy |
| gptkbp:introduced |
gptkb:Thomas_Willis
|
| gptkbp:isAssociatedWith |
autoantibodies against muscle-specific kinase (MuSK)
autoantibodies against acetylcholine receptors thymic hyperplasia |
| gptkbp:isCharacterizedBy |
fluctuating muscle weakness
improvement with rest increased weakness with activity |
| gptkbp:isConsidered |
chronic condition
|
| gptkbp:isCounteredBy |
rheumatoid arthritis
other autoimmune diseases lupus |
| gptkbp:isFoundIn |
Caucasians
|
| gptkbp:isLedBy |
gptkb:African_Americans
Asians |
| gptkbp:isManagedBy |
physical therapy
supportive care lifestyle changes primary care physicians neurologists ongoing treatment specialists in autoimmune diseases |
| gptkbp:isNotableFor |
true
|
| gptkbp:isStudiedIn |
clinical trials
medical research pharmaceutical studies |
| gptkbp:isUsedFor |
gptkb:CT_scan
MRI blood tests intravenous immunoglobulin (IVIG) plasmapheresis |
| gptkbp:researchFocus |
neurology
pharmacology immunology |
| gptkbp:symptoms |
muscle weakness
diplopia ptosis |